UCCS19102 / MAAT-G JIT (Breast) / Magnuson
Research Question:
cancer study
Basic Study Information
Purpose:
Cancer-related cognitive dysfunction (CRCD) affects up to 75% of patients receiving
chemotherapy and older adults are at greater risk of developing CRCD, which can negatively
affect their functional independence and quality of life. Memory and Attention Adaptation
Training (MAAT) is a promising treatment for CRCD that improves perceived cognition
in younger cancer survivors, but needs to be adapted for older adults to address their
unique needs. The proposed study will adapt MAAT for older adults using feedback from
key stakeholders (older adults with cancer and their caregivers), and subsequently
test the ability of MAAT to improve or maintain cognition for older adults with breast
cancer receiving adjuvant chemotherapy.
Location: University of Rochester Medical Center
Lead Researcher (Principal Investigator)
Lead Researcher:
Allison Magnuson
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search